Last reviewed · How we verify

NCT06011811

Cluster Headache Treatment Survey

Completed Last updated 18 February 2026
What this trial tests

trial in Cluster Headache in 2,487 participants. Completed in 28 June 2025.

Timeline
29 June 2023
Primary endpoint
28 June 2025
28 June 2025

Quick facts

Lead sponsorThe University of Texas Health Science Center, Houston
StatusCompleted
Study typeOBSERVATIONAL
Enrollment2,487
Start date29 June 2023
Primary completion28 June 2025
Estimated completion28 June 2025
Sites1 location across United States

Conditions studied

Sponsor

The University of Texas Health Science Center, Houston

Who can join

18 and older, any sex, with Cluster Headache. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The objective of this study is to survey patients with cluster headache about treatment effectiveness and their views on treatments. Participants will complete one brief questionnaire online.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Cluster Headache

Currently open trials in the same condition.

Other The University of Texas Health Science Center, Houston trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06011811.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing